A Randomized, Open-Label Phase II Trial of Volasertib as Monotherapy and in Combination With Standard-Dose Pemetrexed Compared With Pemetrexed Monotherapy in Second-Line Treatment for Non–Small-Cell Lung Cancer
Titel:
A Randomized, Open-Label Phase II Trial of Volasertib as Monotherapy and in Combination With Standard-Dose Pemetrexed Compared With Pemetrexed Monotherapy in Second-Line Treatment for Non–Small-Cell Lung Cancer
Auteur:
Ellis, Peter M. Leighl, Natasha B. Hirsh, Vera Reaume, M. Neil Blais, Normand Wierzbicki, Rafal Sadrolhefazi, Behbood Gu, Yu Liu, Dan Pilz, Korinna Chu, Quincy